These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 17168190)
21. Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen. Nachtigall L; Casson P; Lucas J; Schofield V; Melson C; Simon JA Gynecol Endocrinol; 2011 Jan; 27(1):39-48. PubMed ID: 21142609 [TBL] [Abstract][Full Text] [Related]
22. Hypoactive sexual desire disorder in postmenopausal women. Nappi RE; Wawra K; Schmitt S Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156 [TBL] [Abstract][Full Text] [Related]
23. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues. Warnock JK; Bundren JC; Morris DW Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489 [TBL] [Abstract][Full Text] [Related]
24. Boosting desire: what works for women. Johns Hopkins Med Lett Health After 50; 2007 Mar; 19(1):6-7. PubMed ID: 17342841 [No Abstract] [Full Text] [Related]
25. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire? Slomski A JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073 [No Abstract] [Full Text] [Related]
26. Study identifies effective testosterone dose for women. Harv Womens Health Watch; 2014 Nov; 22(3):8. PubMed ID: 26080465 [No Abstract] [Full Text] [Related]
28. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women". Goldstein I J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531 [No Abstract] [Full Text] [Related]
29. Androgen therapy for menopausal women. Carlson ES; Li S Clin Excell Nurse Pract; 1998 Nov; 2(6):324-8. PubMed ID: 12596834 [TBL] [Abstract][Full Text] [Related]
30. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application. Raza S; Baig M; Ali J; Rizvi S Int J Impot Res; 2008; 20(2):226-8. PubMed ID: 17851581 [TBL] [Abstract][Full Text] [Related]
31. Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire. van Anders SM; Chernick AB; Chernick BA; Hampson E; Fisher WA J Sex Marital Ther; 2005; 31(3):173-85. PubMed ID: 16020137 [TBL] [Abstract][Full Text] [Related]
32. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo. Flyckt RL; Liu J; Frasure H; Wekselman K; Buch A; Kingsberg SA Menopause; 2009; 16(4):680-8. PubMed ID: 19325500 [TBL] [Abstract][Full Text] [Related]
33. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder. Abdallah RT; Simon JA Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596 [TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for women's sexual dysfunction. Basson R Expert Opin Pharmacother; 2009 Jul; 10(10):1631-48. PubMed ID: 19527189 [TBL] [Abstract][Full Text] [Related]
35. Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose? Reynolds PL J Fam Pract; 2000 Dec; 49(12):1148. PubMed ID: 11132065 [No Abstract] [Full Text] [Related]
36. [Treatment of sexual indifference and discontent in women by administration of androgens]. Heczko P; Mohapl P Cesk Gynekol; 1975 Apr; 40(3):220-1. PubMed ID: 1131970 [No Abstract] [Full Text] [Related]
37. Psychological and sexual aspects of the menopause. Montgomery JC; Studd JW Br J Hosp Med; 1991 May; 45(5):300-2. PubMed ID: 2065234 [TBL] [Abstract][Full Text] [Related]
38. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835 [TBL] [Abstract][Full Text] [Related]
39. Testosterone for low libido in postmenopausal women not using systemic oestrogen therapy. Davis SR Med J Aust; 2009 Aug; 191(3):134-5. PubMed ID: 19645638 [TBL] [Abstract][Full Text] [Related]
40. [Is there a pharmacotherapy for libido disturbances in men?]. Köhn FM Urologe A; 2006 Aug; 45(8):999-1001. PubMed ID: 16832642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]